ZERBINI, MARIALUISA
 Distribuzione geografica
Continente #
NA - Nord America 3388
EU - Europa 3343
AS - Asia 1457
AF - Africa 204
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
SA - Sud America 2
Totale 8400
Nazione #
US - Stati Uniti d'America 3375
GB - Regno Unito 1266
VN - Vietnam 629
UA - Ucraina 574
CN - Cina 519
SE - Svezia 400
IT - Italia 327
DE - Germania 276
IN - India 225
RU - Federazione Russa 172
FR - Francia 170
EE - Estonia 84
ZA - Sudafrica 84
TG - Togo 72
SC - Seychelles 48
JP - Giappone 35
IR - Iran 25
GR - Grecia 19
IE - Irlanda 13
CA - Canada 12
BE - Belgio 11
NL - Olanda 10
UZ - Uzbekistan 9
LB - Libano 6
CH - Svizzera 5
RO - Romania 5
AT - Austria 4
EU - Europa 3
MY - Malesia 3
AU - Australia 2
CZ - Repubblica Ceca 2
MD - Moldavia 2
BR - Brasile 1
CR - Costa Rica 1
ES - Italia 1
HK - Hong Kong 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8400
Città #
Southend 1100
Fairfield 458
Dong Ket 448
Jacksonville 404
Wilmington 244
Ann Arbor 243
Princeton 239
Woodbridge 232
Houston 221
Seattle 205
Chandler 198
Ashburn 175
Cambridge 156
Padova 115
Westminster 115
Nanjing 106
Berlin 85
Medford 73
Lomé 72
Saint Petersburg 63
Shenyang 53
Mahé 47
Jinan 46
Redwood City 37
Nanchang 36
Tokyo 35
Milan 34
Changsha 33
Beijing 31
Hebei 31
Tianjin 28
San Diego 25
Verona 25
Bologna 23
Des Moines 23
Jiaxing 21
San Venanzo 17
Zhengzhou 17
Norwalk 16
Ningbo 14
Taizhou 14
Hangzhou 13
Haikou 12
Brussels 11
Dublin 11
Falls Church 11
Kuban 11
Taiyuan 11
Toronto 10
Ardabil 9
Dearborn 8
Guangzhou 8
Lanzhou 8
Monmouth Junction 8
Kunming 7
Leawood 7
Zanjan 7
Andover 6
Frankfurt Am Main 6
Augusta 5
Changchun 5
Shanghai 5
Buffalo 4
Fuzhou 4
Groningen 4
Phoenix 4
Plauen 4
San Jose 4
San Mateo 4
Ameno 3
Hefei 3
Kuala Lumpur 3
London 3
Moscow 3
Redmond 3
Tehran 3
Athens 2
Atlanta 2
Chicago 2
Chisinau 2
Hanover 2
Hägersten 2
Kashan 2
Las Vegas 2
Muizenberg 2
Napoli 2
New York 2
Provo 2
San Francisco 2
Trieste 2
Almaty 1
Anzio 1
Auckland 1
Bratislava 1
Budrio 1
Cernobbio 1
Changle 1
Colombo 1
Dalian 1
Delhi 1
Totale 5824
Nome #
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 149
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 128
Comparison of Abbott RealTime High Risk HPV and Hybrid Capture 2 for the detection of high-risk HPV DNA in a referral population setting 124
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis 123
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 122
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 116
Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma 113
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 109
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 108
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 107
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 107
Analysis of HPV16 E6*I-II transcripts in cervical samples 106
Parvovirus in gravidanza: possibili conseguenze della trasmissione verticale 106
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 105
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 104
A proteomic approach to the analysis of B19 capsid proteins 104
Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C(HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy 103
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 103
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 102
Recurrent erythema in patients with long-term parvovirus B19 infection 99
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 98
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 98
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 97
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 95
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 94
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 93
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 92
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 91
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 89
Analisi della competenza funzionale di cloni genomici di parvovirus B19 89
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 89
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 88
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 87
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 87
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 86
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 86
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 85
Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis 85
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 85
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 84
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 84
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 84
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 84
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 81
Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study. 81
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 80
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 80
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 79
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 78
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 76
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 76
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 76
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 76
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 75
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 75
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 74
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 74
Espressione e purificazione di gamma-interferon bovino bioattivo in baculovirus 73
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 73
Detection of parvovirus B19 IgG: choice of antigens and serological tests 72
Factors predicting the outcome of conservately trated adenocarcinoma in situ of uterine cervix: an analysis of 166 cases 71
Evidence of human bocavirus viremia in healthy blood donors. 71
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 70
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 70
Diagnosi virologica di infezione da papillomavirus umani 69
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 69
Lo studio PATER: Population-Based Frequency Assessment of HPV Infections in Borderline Pap Tests in the Emilia-Romagna Region 68
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 67
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 67
Implicazioni nella progressione della patologia cervicale 66
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 66
La biologia molecolare nella diagnosi delle infezioni da HPV 65
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 65
Analysis of the functional competence of genomic clones of Parvovirus B19 65
B19 parvovirus infections: diagnostic technologies 64
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 64
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 63
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 62
PNA-based probe for quantitative chemiluminescent in situ hybridisation imaging of cellular parvovirus B19 replication kinetics 62
Sviluppo di un saggio di spettrometria di massa, ad elevata processività, per la ricerca e genotipizzazione di 12 HPV ad alto rischio oncogeno 62
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 61
Nuovo saggio FISH per la ricerca del DNA di HPV combinato ad IHC chemiluminescente per la quantificazione di p16 INK4A in lesioni cervicali 61
Clonazione, espressione e purificazione di g-IFN bovino ricombinante in baculovirus 61
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 60
Human papillomavirus in melanoma: reply from authors 60
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 59
Parvovirus B19-derived fetal complications following gestational infection. 59
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 59
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 58
High-throughput type-specific detection of HPV using MassARRAY technology 57
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 57
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 56
Expression of bioactive recombinant bovine interferon-gamma using baculovirus 56
Parvovirus B19 in pregnancy: possible consequence of vertical transmission 56
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 54
Human parvovirus B19 experimental infection in the hepatocellular carcinoma cell lines HepG2 50
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 50
B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines – a quantitative analysis by real-time PCR 50
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions 49
Transduction activity and properties of genomic and subgenomic clones of parvovirus B19 47
Totale 8033
Categoria #
all - tutte 10613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10613


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018276 0000 33 08 002539
2018/20191045 441088195 2595 8341 10517049122
2019/20202566 5137279182 200228 255340 27518596141
2020/20211970 37110952100 27119 32101 12597105732
2021/20222085 140105142226 177107 25112 62215358416
2022/2023667 251328880 00 00 0000
Totale 8628